MaxCyte MXCT Q1 2026 Earnings EPS Surprises Positively on LowerThanExpected Loss Revenue Not Disclosed ANRO Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues Investment in Pipeline LifeMD Q1 2026 Earnings EPS Beats Estimates by 1166 as Stock Rises 119 OneStream Q4 2025 Earnings Strong Earnings Beat with 137 Surprise TSSI Q1 2026 Earnings Massive EPS Beat Fails to Lift Stock as Revenue Remains Undisclosed LivePerson Q1 2026 Earnings EPS Beat Drives Positive Stock Move Amid Continued Turnaround